Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Drugs and Chemicals›Glycerol
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Glycerol

Drugs and Chemicals · NLM MeSH · updated 2026-10-31 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 4 min read

A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (871 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism. It is used as a solvent, emollient, pharmaceutical agent, or sweetening agent.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: Glycerin; Glycerine; 1,2,3-Propanetriol; 1,2,3-Trihydroxypropane.

Where it fits in the MeSH classification

Broader topics
Triose Sugar Alcohols

Research landscape

PubMed indexes 28,437 records tagged with the MeSH heading “Glycerol” (counts retrieved 2026-10-31). 3,410 of them (12.0%) were published from 2020 onward, and the busiest period so far is through 1999 with 14,374 records.

Reviews account for 832 records (2.9%) and meta-analyses for 24. Randomized controlled trials number 631 (2.2%) as a share of all records on the topic.

PubMed records by publication periodthrough 1999: 14,374 records; 2000-2009: 4,631 records; 2010-2019: 6,022 records; 2020 onward: 3,410 records14,374through 19994,6312000-20096,0222010-20193,4102020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 199914,374
2000-20094,631
2010-20196,022
2020 onward3,410
Share of records by publication typeReviews: 2.9 percent; Meta-analyses: 0.1 percent; Randomized controlled trials: 2.2 percentReviews2.9% (832)Meta-analyses0.1% (24)Randomized controlled trials2.2% (631)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 28,437 PubMed records
TypeRecordsShare
Reviews8322.9%
Meta-analyses240.1%
Randomized controlled trials6312.2%

Method: PubMed query "Glycerol"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.

Reading the evidence in drugs and chemicals

Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Human adipose glycerol flux is regulated by a pH gate in AQP10
Gotfryd K, Mósca AF, Missel JW, Truelsen SF, Wang K, Spulber M, et al.
2018Research article
Design not recorded in structured metadata
106cc by
PMID 30420639 · DOI · PMC6232157
Yeast's balancing act between ethanol and glycerol production in low-alcohol wines
Goold HD, Kroukamp H, Williams TC, Paulsen IT, Varela C, Pretorius IS
2017Review article
Design not recorded in structured metadata
83cc by
PMID 28083938 · DOI · PMC5328816
Tracing the lactate shuttle to the mitochondrial reticulum
Brooks GA, Curl CC, Leija RG, Osmond AD, Duong JJ, Arevalo JA
2022Review article
Design not recorded in structured metadata
81cc by
PMID 36075947 · DOI · PMC9534995
Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases
Madiraju SRM, Possik E, Al-Mulla F, Nolan CJ, Prentki M
2026Review article
Design not recorded in structured metadata
16cc by
PMID 40927981 · DOI · PMC12795705

Human adipose glycerol flux is regulated by a pH gate in AQP10 [1]

Research article Gotfryd K, Mósca AF, Missel JW, Truelsen SF, Wang K, Spulber M, et al. · · 2018 · cited 106 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Obesity is a major threat to global health and metabolically associated with glycerol homeostasis.
Closing excerpt
Thus, targeting the cytoplasmic gate to induce constitutive glycerol secretion may offer an attractive option for treating obesity and related complications.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (132 words)

Obesity is a major threat to global health and metabolically associated with glycerol homeostasis. Here we demonstrate that in human adipocytes, the decreased pH observed during lipolysis (fat burning) correlates with increased glycerol release and stimulation of aquaglyceroporin AQP10. The crystal structure of human AQP10 determined at 2.3 Å resolution unveils the molecular basis for pH modulation-an exceptionally wide selectivity (ar/R) filter and a unique cytoplasmic gate. Structural and functional (in vitro and in vivo) analyses disclose a glycerol-specific pH-dependence and pinpoint pore-lining His80 as the pH-sensor. Molecular dynamics simulations indicate how gate opening is achieved. These findings unravel a unique type of aquaporin regulation important for controlling body fat mass. Thus, targeting the cytoplasmic gate to induce constitutive glycerol secretion may offer an attractive option for treating obesity and related complications.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 30420639 · DOI · PMC6232157

Yeast's balancing act between ethanol and glycerol production in low-alcohol wines [2]

Review article Goold HD, Kroukamp H, Williams TC, Paulsen IT, Varela C, Pretorius IS · · 2017 · cited 83 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Alcohol is fundamental to the character of wine, yet too much can put a wine off-balance.
Closing excerpt
It also casts new light on yeast strain development programmes which, bolstered by synthetic genomics, could potentially overcome these challenges.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (304 words)

Alcohol is fundamental to the character of wine, yet too much can put a wine off-balance. A wine is regarded to be well balanced if its alcoholic strength, acidity, sweetness, fruitiness and tannin structure complement each other so that no single component dominates on the palate. Balancing a wine's positive fruit flavours with the optimal absolute and relative concentration of alcohol can be surprisingly difficult. Over the past three decades, consumers have increasingly demanded wine with richer and riper fruit flavour profiles. In response, grape and wine producers have extended harvest times to increase grape maturity and enhance the degree of fruit flavours and colour intensity. However, a higher degree of grape maturity results in increased grape sugar concentration, which in turn results in wines with elevated alcohol concentration. On average, the alcohol strength of red wines from many warm wine-producing regions globally rose by about 2% (v/v) during this period. Notwithstanding that many of these 'full-bodied, fruit-forward' wines are well balanced and sought after, there is also a significant consumer market segment that seeks lighter styles with less ethanol-derived 'hotness' on the palate. Consumer-focussed wine producers are developing and implementing several strategies in the vineyard and winery to reduce the alcohol concentration in wines produced from well-ripened grapes. In this context, Saccharomyces cerevisiae wine yeasts have proven to be a pivotal strategy to reduce ethanol formation during the fermentation of grape musts with high sugar content (> 240 g l-1 ). One of the approaches has been to develop 'low-alcohol' yeast strains which work by redirecting their carbon metabolism away from ethanol production to other metabolites, such as glycerol. This article reviews the current challenges of producing glycerol at the expense of ethanol. It also casts new light on yeast strain development programmes which, bolstered by synthetic genomics, could potentially overcome these challenges.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 28083938 · DOI · PMC5328816

Tracing the lactate shuttle to the mitochondrial reticulum [3]

Review article Brooks GA, Curl CC, Leija RG, Osmond AD, Duong JJ, Arevalo JA · · 2022 · cited 81 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Isotope tracer infusion studies employing lactate, glucose, glycerol, and fatty acid isotope tracers were central to the deduction and demonstration of the Lactate Shuttle at the whole-body level.
Closing excerpt
Lactate shuttling between driver and recipient cells depends on concentration gradients created by the mitochondrial respiratory apparatus in recipient cells for oxidative disposal of lactate.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (215 words)

Isotope tracer infusion studies employing lactate, glucose, glycerol, and fatty acid isotope tracers were central to the deduction and demonstration of the Lactate Shuttle at the whole-body level. In concert with the ability to perform tissue metabolite concentration measurements, as well as determinations of unidirectional and net metabolite exchanges by means of arterial-venous difference (a-v) and blood flow measurements across tissue beds including skeletal muscle, the heart and the brain, lactate shuttling within organs and tissues was made evident. From an extensive body of work on men and women, resting or exercising, before or after endurance training, at sea level or high altitude, we now know that Organ-Organ, Cell-Cell, and Intracellular Lactate Shuttles operate continuously. By means of lactate shuttling, fuel-energy substrates can be exchanged between producer (driver) cells, such as those in skeletal muscle, and consumer (recipient) cells, such as those in the brain, heart, muscle, liver and kidneys. Within tissues, lactate can be exchanged between white and red fibers within a muscle bed and between astrocytes and neurons in the brain. Within cells, lactate can be exchanged between the cytosol and mitochondria and between the cytosol and peroxisomes. Lactate shuttling between driver and recipient cells depends on concentration gradients created by the mitochondrial respiratory apparatus in recipient cells for oxidative disposal of lactate.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 36075947 · DOI · PMC9534995

Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases [4]

Review article Madiraju SRM, Possik E, Al-Mulla F, Nolan CJ, Prentki M · · 2026 · cited 16 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Glycerol and glycerol-3-phosphate (Gro3P) are key metabolites at the intersection of carbohydrate, lipid, and energy metabolism.
Closing excerpt
Relevant to chronic metabolic diseases, cancer and aging, glycerol and Gro3P present important translational implications and thus warrant much more attention.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (220 words)

Glycerol and glycerol-3-phosphate (Gro3P) are key metabolites at the intersection of carbohydrate, lipid, and energy metabolism. Their production and usage are organismal and cell-type specific. Glycerol has unique physicochemical properties enabling it to function as an osmolyte, protein structure stabilizer, and an antimicrobial and antifreeze agent, important to the preservation of many biological functions. Glycerol and Gro3P are implicated in many physiological and disease processes relating to energy metabolism, thermoregulation, hydration, skin health, male fertility, aging, and cancer. Glycerol has countless applications in the food, pharmaceutical, and cosmetics industries. It is used as a sweetener, preservative, thickening agent, humectant, osmolyte, and cryoprotectant. It is widely used in skin and wound care products, laxatives, in cell and tissue preservation, and in medicines for numerous conditions. Here, we review the multiple uses and functions of glycerol and Gro3P and associated transporters, enzymes, and target genes in health, senescence, and disease. We discuss the evidence that glycerol may be present at much higher levels in tissues and cells than in the blood. We bring particular focus to the newly identified glycerol shunt in the direct formation of glycerol independent of lipolysis and as a pathway allowing cells to adapt to various stresses. Relevant to chronic metabolic diseases, cancer and aging, glycerol and Gro3P present important translational implications and thus warrant much more attention.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 40927981 · DOI · PMC12795705

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation [5]
    Gelderblom H, Verweij J, Nooter K, Sparreboom A · Eur J Cancer · 2001 · cited 1,154 times (Europe PMC)
  • Research article Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis [6]
    Yen CL, Stone SJ, Koliwad S, Harris C, Farese RV · J Lipid Res · 2008 · cited 840 times (Europe PMC)
  • Research article Glycerol: a promising and abundant carbon source for industrial microbiology [7]
    da Silva GP, Mack M, Contiero J · Biotechnol Adv · 2009 · cited 441 times (Europe PMC)
  • Research article Glyceroneogenesis and the triglyceride/fatty acid cycle [8]
    Reshef L, Olswang Y, Cassuto H, Blum B, Croniger CM, Kalhan SC, et al. · J Biol Chem · 2003 · cited 367 times (Europe PMC)
  • Research article Glycerol dissimilation and its regulation in bacteria [9]
    Lin EC · Annu Rev Microbiol · 1976 · cited 346 times (Europe PMC)
  • Research article Dendritic polyglycerols for biomedical applications [10]
    Calderón M, Calderón M, Quadir MA, Sharma SK, Haag R · Adv Mater · 2010 · cited 326 times (Europe PMC)

References

  1. Gotfryd K, Mósca AF, Missel JW, Truelsen SF, Wang K, Spulber M, et al.. Human adipose glycerol flux is regulated by a pH gate in AQP10. . 2018. PMID 30420639 · DOI · PMC6232157
  2. Goold HD, Kroukamp H, Williams TC, Paulsen IT, Varela C, Pretorius IS. Yeast's balancing act between ethanol and glycerol production in low-alcohol wines. . 2017. PMID 28083938 · DOI · PMC5328816
  3. Brooks GA, Curl CC, Leija RG, Osmond AD, Duong JJ, Arevalo JA. Tracing the lactate shuttle to the mitochondrial reticulum. . 2022. PMID 36075947 · DOI · PMC9534995
  4. Madiraju SRM, Possik E, Al-Mulla F, Nolan CJ, Prentki M. Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases. . 2026. PMID 40927981 · DOI · PMC12795705
  5. Gelderblom H, Verweij J, Nooter K, Sparreboom A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur J Cancer. 2001. PMID 11527683 · DOI
  6. Yen CL, Stone SJ, Koliwad S, Harris C, Farese RV. Thematic review series: glycerolipids. DGAT enzymes and triacylglycerol biosynthesis. J Lipid Res. 2008. PMID 18757836 · DOI · PMC3837458
  7. da Silva GP, Mack M, Contiero J. Glycerol: a promising and abundant carbon source for industrial microbiology. Biotechnol Adv. 2009. PMID 18775486 · DOI
  8. Reshef L, Olswang Y, Cassuto H, Blum B, Croniger CM, Kalhan SC, et al.. Glyceroneogenesis and the triglyceride/fatty acid cycle. J Biol Chem. 2003. PMID 12788931 · DOI
  9. Lin EC. Glycerol dissimilation and its regulation in bacteria. Annu Rev Microbiol. 1976. PMID 825019 · DOI
  10. Calderón M, Calderón M, Quadir MA, Sharma SK, Haag R. Dendritic polyglycerols for biomedical applications. Adv Mater. 2010. PMID 20217684 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-31.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • DithiothreitolDrugs and Chemicals
  • ErythritolDrugs and Chemicals
  • InositolDrugs and Chemicals
  • Inositol 1,4,5-TrisphosphateDrugs and Chemicals
  • Inositol PhosphatesDrugs and Chemicals
  • IsosorbideDrugs and Chemicals

All 546 articles in Drugs and Chemicals →

At a glance

28,437
PubMed records on this heading
12%
published since 2020
832
review articles
631
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-31; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • DithiothreitolDrugs and Chemicals
  • ErythritolDrugs and Chemicals
  • InositolDrugs and Chemicals
  • Inositol 1,4,5-TrisphosphateDrugs and Chemicals
  • Inositol PhosphatesDrugs and Chemicals

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support